Artemisinin IV/IM Therapy

Artemisinin (Artemisia annua) is derived from extracts of sweet wormwood and is well established for the treatment of malaria (including highly drug-resistant strains) and has shown potent and broad anticancer properties. Its efficacy also extends to phylogenetically unrelated infections including anti-SARS/Coronavirus effects. It is important to note that it was not specifically to the novel COVID-19 virus, but still within the same class.

Artemisia (Artemisinin) itself is not generally highly potent and cannot be regarded as a cure. Nevertheless, it can be used as a complementary treatment that may elevate recovery rates when combine with other treatments. This is primarily due to its natural anti-inflammatory and immunoregulatory properties. That being said, Artemisinin can be given intravenously once per week for 4 weeks as an immune boosting measure. This can also be given intramuscularly three times per week for 4 weeks to achieve similar effects (of course not as potent as the IV, however, since volume-wise IM injections must be dosed much lower).

Give us a call today if you’d like more information or to schedule an appointment!



  1. Li, S. Y. et al.  Res.67, 18–23 (2005). Article
  2. Lin, C. W. et al.  Res.68, 36–42 (2005). Article
  3. Ryu, Y. B. et al.  Med. Chem.18, 7940–7947 (2010) Article
  4. Yu, M. S. et al. Bioorg. Med. Chem. Lett. 22, 4049–4054 (2012). Article
  5. Lau, K. M. et al.  Ethnopharmacol.118, 79–85 (2008).Article

Accessibility Toolbar

Scroll to Top